Hemodynamic Effects of Guideline-Based Sedation in Mechanically Ventilated Adults: A Multicenter Observational Analysis.

IF 2.7 Q4 Medicine
Critical care explorations Pub Date : 2025-09-05 eCollection Date: 2025-09-01 DOI:10.1097/CCE.0000000000001313
Kiyan Heybati, Guozhen Xie, Jiawen Deng, Allan J Walkey, Ognjen Gajic, Hemang Yadav
{"title":"Hemodynamic Effects of Guideline-Based Sedation in Mechanically Ventilated Adults: A Multicenter Observational Analysis.","authors":"Kiyan Heybati, Guozhen Xie, Jiawen Deng, Allan J Walkey, Ognjen Gajic, Hemang Yadav","doi":"10.1097/CCE.0000000000001313","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>Propofol is a first-line sedative for adults receiving invasive mechanical ventilation (IMV). However, it can contribute to hemodynamic instability, especially during intubation. The magnitude, timing, risk factors, and variability of sedation-associated mean arterial pressure (MAP) changes remain poorly characterized in ICU settings.</p><p><strong>Objectives: </strong>To quantify MAP changes following propofol sedation, identify risk factors for hemodynamic instability, and characterize associated interventions.</p><p><strong>Design: </strong>Retrospective cohort study. The primary outcome was MAP change within 2 hours following sedation. Secondary outcomes included vasopressor use and hypotension (MAP ≤ 60 mm Hg). Mixed-effects modeling was used to account for individual patient differences.</p><p><strong>Setting and participants: </strong>Adults (≥ 18 yrs old) who required IMV and received greater than or equal to 6 consecutive hours of propofol infusion, between May 5th, 2018, and July 31st, 2024, in 11 ICUs across the Mayo Clinic, spanning 5 hospitals in 4 states.</p><p><strong>Main outcomes and measures: </strong>The primary outcome was the change in MAP within 2 hours following the initiation of propofol-based sedation.</p><p><strong>Results: </strong>Across 16,418 patients, 25.2% were on vasopressors before sedation initiation. Among the remaining 12,281 patients, 40.3% required vasopressors and 7.7% experienced hypotension within 2 hours of sedation. Propofol-based sedation was associated with a MAP reduction within the first 30 minutes (-6.58 mm Hg; 95% CI, -6.85 to -6.32; p < 0.001). There was substantial interpatient variability in both baseline MAP, and MAP decline after sedation (9.5 and 40.9% between-patient differences, respectively). Higher Sequential Organ Failure Assessment (SOFA) scores (-0.31 mm Hg/point), older age (-0.04 mm Hg/yr), and male sex (-0.47 mm Hg) were associated with lower MAP. Patients with higher illness severity experienced progressively greater MAP decline over time (-0.20 mm Hg/hr/SOFA point; p < 0.001).</p><p><strong>Conclusions and relevance: </strong>Propofol-based sedation was associated with clinically significant hemodynamic effects requiring intervention in the early post-intubation period. The marked interpatient variability in hemodynamic responses highlights the importance of personalized management approaches, including risk stratification based on age, sex, and illness severity.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":"7 9","pages":"e1313"},"PeriodicalIF":2.7000,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12416995/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical care explorations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/CCE.0000000000001313","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Importance: Propofol is a first-line sedative for adults receiving invasive mechanical ventilation (IMV). However, it can contribute to hemodynamic instability, especially during intubation. The magnitude, timing, risk factors, and variability of sedation-associated mean arterial pressure (MAP) changes remain poorly characterized in ICU settings.

Objectives: To quantify MAP changes following propofol sedation, identify risk factors for hemodynamic instability, and characterize associated interventions.

Design: Retrospective cohort study. The primary outcome was MAP change within 2 hours following sedation. Secondary outcomes included vasopressor use and hypotension (MAP ≤ 60 mm Hg). Mixed-effects modeling was used to account for individual patient differences.

Setting and participants: Adults (≥ 18 yrs old) who required IMV and received greater than or equal to 6 consecutive hours of propofol infusion, between May 5th, 2018, and July 31st, 2024, in 11 ICUs across the Mayo Clinic, spanning 5 hospitals in 4 states.

Main outcomes and measures: The primary outcome was the change in MAP within 2 hours following the initiation of propofol-based sedation.

Results: Across 16,418 patients, 25.2% were on vasopressors before sedation initiation. Among the remaining 12,281 patients, 40.3% required vasopressors and 7.7% experienced hypotension within 2 hours of sedation. Propofol-based sedation was associated with a MAP reduction within the first 30 minutes (-6.58 mm Hg; 95% CI, -6.85 to -6.32; p < 0.001). There was substantial interpatient variability in both baseline MAP, and MAP decline after sedation (9.5 and 40.9% between-patient differences, respectively). Higher Sequential Organ Failure Assessment (SOFA) scores (-0.31 mm Hg/point), older age (-0.04 mm Hg/yr), and male sex (-0.47 mm Hg) were associated with lower MAP. Patients with higher illness severity experienced progressively greater MAP decline over time (-0.20 mm Hg/hr/SOFA point; p < 0.001).

Conclusions and relevance: Propofol-based sedation was associated with clinically significant hemodynamic effects requiring intervention in the early post-intubation period. The marked interpatient variability in hemodynamic responses highlights the importance of personalized management approaches, including risk stratification based on age, sex, and illness severity.

Abstract Image

Abstract Image

Abstract Image

基于指南的镇静对机械通气成人的血流动力学影响:一项多中心观察分析。
重要性:异丙酚是接受有创机械通气(IMV)的成人的一线镇静剂。然而,它可能导致血流动力学不稳定,特别是在插管期间。在ICU环境中,镇静相关的平均动脉压(MAP)变化的幅度、时间、危险因素和可变性仍然缺乏特征。目的:量化异丙酚镇静后MAP的变化,确定血流动力学不稳定的危险因素,并确定相关干预措施的特征。设计:回顾性队列研究。主要终点是镇静后2小时内MAP的变化。次要结局包括使用血管加压剂和低血压(MAP≤60 mm Hg)。混合效应模型用于解释个体患者的差异。环境和参与者:2018年5月5日至2024年7月31日期间,在梅奥诊所横跨4个州5家医院的11个icu中,需要IMV并接受大于或等于连续6小时异丙酚输注的成年人(≥18岁)。主要结局和指标:主要结局为异丙酚镇静开始后2小时内MAP的变化。结果:在16,418例患者中,25.2%的患者在镇静开始前使用血管加压药物。在剩余的12281例患者中,40.3%需要血管加压药物,7.7%在镇静2小时内出现低血压。基于异丙酚的镇静与前30分钟内MAP降低相关(-6.58 mm Hg; 95% CI, -6.85至-6.32;p < 0.001)。镇静后基线MAP和MAP下降的患者间差异很大(患者间差异分别为9.5%和40.9%)。较高的顺序器官衰竭评估(SOFA)评分(-0.31 mm Hg/分)、年龄(-0.04 mm Hg/年)和男性(-0.47 mm Hg)与较低的MAP相关。随着时间的推移,病情严重程度越高的患者MAP下降越严重(-0.20 mm Hg/hr/SOFA点;p < 0.001)。结论及相关性:异丙酚镇静与临床显著的血流动力学影响相关,需要在插管后早期进行干预。患者血流动力学反应的显著差异突出了个性化管理方法的重要性,包括基于年龄、性别和疾病严重程度的风险分层。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.70
自引率
0.00%
发文量
0
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信